Analystreport

ProQR Therapeutics (NASDAQ: PRQR) had its price target lowered by analysts at JMP Securities from $8.00 to $5.00. They now have a "market outperform" rating on the

ProQR Therapeutics N.V. - Ordinary Shares  (PRQR) 
Last proqr therapeutics n.v. - ordinary shares earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: proqr.com